Books > Medicine > General issues > Medical equipment & techniques > Medical research
|
Buy Now
Stem Cell Therapies - Opportunities for Ensuring the Quality and Safety of Clinical Offerings: Summary of a Joint Workshop by the Institute of Medicine, the National Academy of Sciences, and the International Society for Stem Cell Research (Paperback)
Loot Price: R1,062
Discovery Miles 10 620
|
|
Stem Cell Therapies - Opportunities for Ensuring the Quality and Safety of Clinical Offerings: Summary of a Joint Workshop by the Institute of Medicine, the National Academy of Sciences, and the International Society for Stem Cell Research (Paperback)
Expected to ship within 12 - 17 working days
|
Stem cells offer tremendous promise for advancing health and
medicine. Whether being used to replace damaged cells and organs or
else by supporting the body's intrinsic repair mechanisms, stem
cells hold the potential to treat such debilitating conditions as
Parkinson's disease, diabetes, and spinal cord injury. Clinical
trials of stem cell treatments are under way in countries around
the world, but the evidence base to support the medical use of stem
cells remains limited. Despite this paucity of clinical evidence,
consumer demand for treatments using stem cells has risen, driven
in part by a lack of available treatment options for debilitating
diseases as well as direct-to-consumer advertising and public
portrayals of stem cell-based treatments. Clinics that offer stem
cell therapies for a wide range of diseases and conditions have
been established throughout the world, both in newly industrialized
countries such as China, India, and Mexico and in developed
countries such as the United States and various European nations.
Though these therapies are often promoted as being established and
effective, they generally have not received stringent regulatory
oversight and have not been tested with rigorous trials designed to
determine their safety and likely benefits. In the absence of
substantiated claims, the potential for harm to patients - as well
as to the field of stem cell research in general - may outweigh the
potential benefits. To explore these issues, the Institute of
Medicine, the National Academy of Sciences, and the International
Society for Stem Cell Research held a workshop in November 2013.
Stem Cell Therapies summarizes the workshop. Researchers,
clinicians, patients, policy makers, and others from North America,
Europe, and Asia met to examine the global pattern of treatments
and products being offered, the range of patient experiences, and
options to maximize the well-being of patients, either by
protecting them from treatments that are dangerous or ineffective
or by steering them toward treatments that are effective. This
report discusses the current environment in which patients are
receiving unregulated stem cell offerings, focusing on the
treatments being offered and their risks and benefits. The report
considers the evidence base for clinical application of stem cell
technologies and ways to assure the quality of stem cell offerings.
Table of Contents Front Matter 1 Introduction and Themes of the
Workshop 2 Stem Cell Therapies - Knowns and Unknowns 3 Patients'
Experiences 4 Comparative Regulatory and Legal Frameworks 5 The
Roles of Professional Societies 6 Moving Forward References
Appendix A: Workshop Agenda Appendix B: Speaker Biographical
Sketches Appendix C: Statement of Task Appendix D: Registered
Attendees Appendix E: Glossary
General
Is the information for this product incomplete, wrong or inappropriate?
Let us know about it.
Does this product have an incorrect or missing image?
Send us a new image.
Is this product missing categories?
Add more categories.
Review This Product
No reviews yet - be the first to create one!
|
|
Email address subscribed successfully.
A activation email has been sent to you.
Please click the link in that email to activate your subscription.